Russell Investments Group
SPRB

Russell Investments Group’s Spruce Biosciences SPRB Stock Holding History

Russell Investments Group’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Buy
+217
New +$12.1K ﹤0.01% 3904

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Russell Investments Group's SPRB Position: Q2 2026 in Review

Russell Investments Group opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 217 shares worth $11.7K. The stake represents ﹤0.01% of the portfolio and ranks #3904 among its holdings.

15 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Russell Investments Group held 217 shares of Spruce Biosciences worth $11.7K as of Q2 2026.
  • Spruce Biosciences was a new Russell Investments Group position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3904 holding.
  • 15 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.